CMND-100, a proprietary MEAI-based oral drug candidate, represents a potential breakthrough in AUD treatment, targeting the reduction of alcohol consumption and cravings through a novel mechanism of ...

Plus Texas Health's Surgery Recognition and Medical City Fort Worth's Expansion Milestone.

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its ...

Shares of Jaguar Health common stock to begin trading on split-adjusted basis on March 24, 2025 ...

Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company") a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

Quibim, a global company pioneering imaging biomarkers for precision medicine, announces that its prostate cancer lesion detection capability of its flagship QP-Prostate® CAD solution has received 510 ...

ProKidney Corp. reported Friday a $61.2 million loss in fiscal 2024 as the biotechnology company resumed production and retrenched its growth plans to its Winston-Salem facilities.

U.S. News & World Report: Calling The Shots: Tracking Robert F. Kennedy Jr.'s Moves On Vaccines Since taking the helm of HHS, Robert F. Kennedy Jr. has both backed vaccination as a public health ...

The company also anticipates opportunities for emergency use authorization in international markets before FDA approval. Tivic expects to leverage Entolimod for additional indications, including ...

Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.